Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 164

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

Liraglutide promotes improvements in objective measures of cognitive dysfunction in individuals with mood disorders: A pilot, open-label study

Mansur, Rodrigo B., Ahmed, Juhie, Cha, Danielle S., Woldeyohannes, Hanna O., Subramaniapillai, Mehala, Lovshin, Julie, Lee, Jung G., Lee, Jae-Hon, Brietzke, Elisa, Reininghaus, Eva Z., Sim, Kang, Vinberg, Maj, Rasgon, Natalie, Hajek, Tomas, McIntyre, Roger S. · 2017 · Journal of Affective Disorders

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jad.2016.09.056

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 27 references

Research works printed but not linked: 58

  1. Alvarez, 2005, The expression of GLP-1 receptor mRNA and protein allows the effect of GLP-1 on glucose metabolism in the human hypothalamus and brainstem, J. Neurochem., 92, 798, 10.1111/j.1471-4159.2004.02914.x · DOI · Paper page
  2. Bomfim, 2012, An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer’s disease- associated Abeta oligomers, J. Clin. Investig., 122, 1339, 10.1172/JCI57256 · DOI · Paper page
  3. Bourne, 2013, Neuropsychological testing of cognitive impairment in euthymic bipolar disorder: an individual patient data meta-analysis, Acta Psychiatr. Scand., 128, 149, 10.1111/acps.12133 · DOI · Paper page
  4. Bove, 2013, Metabolic and endocrine correlates of cognitive function in healthy young women, Obesity, 21, 1343, 10.1002/oby.20212 · DOI
  5. Cabou, 2008, Brain glucagon-like peptide-1 regulates arterial blood flow, heart rate, and insulin sensitivity, Diabetes, 57, 2577, 10.2337/db08-0121 · DOI
  6. Calkin, 2015, Insulin resistance and outcome in bipolar disorder, Br. J. Psychiatry, 206, 52, 10.1192/bjp.bp.114.152850 · DOI · Paper page
  7. DanieleG., IozzoP., Molina-CarrionM., LancasterJ., CiociaroD., CersosimoE., TripathyD., TriplittC., FoxP., MusiN., DeFronzoR., GastaldelliA., 2015. . Exenatide Regulates Cerebral Glucose Metabolism in Brain Areas Associated with Glucose Homeostasis and Reward System. Diabetes. · DOI
  8. Darsalia, 2012, Glucagon-like peptide-1 receptor activation reduces ischaemic brain damage following stroke in Type 2 diabetic rats, Clin. Sci. (Lond.), 122, 473, 10.1042/CS20110374 · DOI
  9. Depp, 2012, Meta-analysis of the association between cognitive abilities and everyday functioning in bipolar disorder, Bipolar Disord., 14, 217, 10.1111/j.1399-5618.2012.01011.x · DOI · Paper page
  10. Dias, 2012, Pharmacological approaches in bipolar disorders and the impact on cognition: a critical overview, Acta Psychiatr. Scand., 126, 315, 10.1111/j.1600-0447.2012.01910.x · DOI · Paper page
  11. Drucker, 2003, Enhancing incretin action for the treatment of type 2 diabetes, Diabetes Care, 26, 2929, 10.2337/diacare.26.10.2929 · DOI · Paper page
  12. Engler, 2006, Two-year follow-up of amyloid deposition in patients with Alzheimer’s disease, Brain, 129, 2856, 10.1093/brain/awl178 · DOI · Paper page
  13. Gault, 2008, GLP-1 agonists facilitate hippocampal LTP and reverse the impairment of LTP induced by beta-amyloid, Eur. J. Pharm., 587, 112, 10.1016/j.ejphar.2008.03.025 · DOI
  14. Geijselaers, S.L., Sep, S.J., Stehouwer, C.D., Biessels, G.J., 2014. Glucose regulation, cognition, and brain MRI in type 2 diabetes: a systematic review. Lancet Diabetes Endocrinol. · DOI · Paper page
  15. Gejl, 2012, Glucagon-like peptide-1 decreases intracerebral glucose content by activating hexokinase and changing glucose clearance during hyperglycemia, J. Cereb. Blood Flow. Metab., 32, 2146, 10.1038/jcbfm.2012.118 · DOI
  16. Gengler, 2012, Val(8)GLP-1 rescues synaptic plasticity and reduces dense core plaques in APP/PS1 mice, Neurobiol. Aging, 33, 265, 10.1016/j.neurobiolaging.2010.02.014 · DOI · Paper page
  17. Goldstein, 2013, Obesity and the three-year longitudinal course of bipolar disorder, Bipolar Disord., 15, 284, 10.1111/bdi.12035 · DOI
  18. Gomes, 2013, Cardiovascular risk factors in outpatients with bipolar disorder: a report from the Brazilian Research Network in Bipolar Disorder, Rev. Bras. Psiquiatr, 35, 126, 10.1590/1516-4446-2011-0768 · DOI
  19. Hajek, 2015, Type 2 diabetes mellitus: a potentially modifiable risk factor for neurochemical brain changes in bipolar disorders, Biol. Psychiatry, 77, 295, 10.1016/j.biopsych.2013.11.007 · DOI
  20. Hajek, 2014, Insulin resistance, diabetes mellitus, and brain structure in bipolar disorders, Neuropsychopharmacology, 39, 2910, 10.1038/npp.2014.148 · DOI
  21. Handley, T.E., Ventura, A.D., Browne, J.L., Rich, J., Attia, J.R., Reddy, P., Pouwer, F., Speight, J., 2015. Suicidal ideation reported by adults with Type 1 or Type 2 diabetes: results from Diabetes MILES-Australia. Diabet. Med. · DOI
  22. Heni, 2012, Nasal insulin changes peripheral insulin sensitivity simultaneously with altered activity in homeostatic and reward-related human brain regions, Diabetologia, 55, 1773, 10.1007/s00125-012-2528-y · DOI
  23. Iwai, 2009, The influences of juvenile diabetes on memory and hippocampal plasticity in rats: improving effects of glucagon-like peptide-1, Neurosci. Res, 64, 67, 10.1016/j.neures.2009.01.013 · DOI
  24. Karlamangla, 2014, Biological correlates of adult cognition: midlife in the United States (MIDUS), Neurobiol. Aging, 35, 387, 10.1016/j.neurobiolaging.2013.07.028 · DOI
  25. Katsurada, 2014, Endogenous GLP-1 acts on paraventricular nucleus to suppress feeding: projection from nucleus tractus solitarius and activation of corticotropin-releasing hormone, nesfatin-1 and oxytocin neurons, Biochem. Biophys. Res. Commun., 451, 276, 10.1016/j.bbrc.2014.07.116 · DOI
  26. Kessler, 2005, Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication, Arch. Gen. Psychiatry, 62, 593, 10.1001/archpsyc.62.6.593 · DOI · Paper page
  27. Kleine-Budde, 2014, Cost of illness for bipolar disorder: a systematic review of the economic burden, Bipolar Disord., 16, 337, 10.1111/bdi.12165 · DOI
  28. Levy, 1998, Correct homeostasis model assessment (HOMA) evaluation uses the computer program, Diabetes Care, 21, 2191, 10.2337/diacare.21.12.2191 · DOI · Paper page
  29. Long-Smith, 2013, The diabetes drug liraglutide ameliorates aberrant insulin receptor localisation and signalling in parallel with decreasing both amyloid-beta plaque and glial pathology in a mouse model of Alzheimer’s disease, Neuromolecular Med., 15, 102, 10.1007/s12017-012-8199-5 · DOI
  30. Malloy-Diniz, 2009, Suicide behavior and neuropsychological assessment of type I bipolar patients, J. Affect Disord., 112, 231, 10.1016/j.jad.2008.03.019 · DOI · Paper page
  31. Mansur, 2015, Is there a “metabolic-mood syndrome”? A review of the relationship between obesity and mood disorders, Neurosci. Biobehav. Rev., 52, 89, 10.1016/j.neubiorev.2014.12.017 · DOI · Paper page
  32. Mansur, 2016, Adipokines, metabolic dysfunction and illness course in bipolar disorder, J. Psychiatr. Res., 74, 63, 10.1016/j.jpsychires.2015.12.003 · DOI
  33. Mansur, 2016, Bipolar disorder course, impaired glucose metabolism and antioxidant enzymes activities: a preliminary report, J. Psychiatr. Res., 80, 38, 10.1016/j.jpsychires.2016.05.014 · DOI
  34. Mansur, 2016, Brain-derived neurotrophic factor, impaired glucose metabolism, and bipolar disorder course, Bipolar Disord., 18, 373, 10.1111/bdi.12399 · DOI
  35. Martino, 2008, Heterogeneity in cognitive functioning among patients with bipolar disorder, J. Affect Disord., 109, 149, 10.1016/j.jad.2007.12.232 · DOI · Paper page
  36. McClean, 2014, Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer’s disease, Neuropharmacology, 76, 57, 10.1016/j.neuropharm.2013.08.005 · DOI · Paper page
  37. McClean, 2011, The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer’s disease, J. Neurosci., 31, 6587, 10.1523/JNEUROSCI.0529-11.2011 · DOI · Paper page
  38. McIntyre, 2010, Bipolar disorder and metabolic syndrome: an international perspective, J. Affect. Disord., 126, 366, 10.1016/j.jad.2010.04.012 · DOI · Paper page
  39. McIntyre, 2013, The neuroprotective effects of GLP-1: possible treatments for cognitive deficits in individuals with mood disorders, Behav. Brain Res., 237, 164, 10.1016/j.bbr.2012.09.021 · DOI · Paper page
  40. Mosconi, 2005, Brain glucose metabolism in the early and specific diagnosis of Alzheimer’s disease. FDG-PET studies in MCI and AD, Eur. J. Nucl. Med. Mol. Imaging, 32, 486, 10.1007/s00259-005-1762-7 · DOI · Paper page
  41. Naiberg, 2016, Elevated triglycerides are associated with decreased executive function among adolescents with bipolar disorder, Acta Psychiatr. Scand., 134, 241, 10.1111/acps.12603 · DOI
  42. Parkinson, 2009, Differential patterns of neuronal activation in the brainstem and hypothalamus following peripheral injection of GLP-1, oxyntomodulin and lithium chloride in mice detected by manganese-enhanced magnetic resonance imaging (MEMRI), Neuroimage, 44, 1022, 10.1016/j.neuroimage.2008.09.047 · DOI
  43. Perugi, 2015, General medical conditions in 347 bipolar disorder patients: clinical correlates of metabolic and autoimmune-allergic diseases, J. Affect. Disord., 170, 95, 10.1016/j.jad.2014.08.052 · DOI
  44. Porter, 2010, Four weeks administration of Liraglutide improves memory and learning as well as glycaemic control in mice with high fat dietary-induced obesity and insulin resistance, Diabetes Obes. Metab., 12, 891, 10.1111/j.1463-1326.2010.01259.x · DOI
  45. Ram, 2014, Hypertriglyceridaemic waist phenotype as a simple predictive marker of incident diabetes in Asian-Indian men with prediabetes, Diabet. Med., 31, 1542, 10.1111/dme.12517 · DOI
  46. Richard, 2014, GLP-1 receptor stimulation of the lateral parabrachial nucleus reduces food intake: neuroanatomical, electrophysiological, and behavioral evidence, Endocrinology, 155, 4356, 10.1210/en.2014-1248 · DOI
  47. Rinaman, 1999, Interoceptive stress activates glucagon-like peptide-1 neurons that project to the hypothalamus, Am. J. Physiol., 277, R582
  48. Ruzickova, 2003, Clinical features of bipolar disorder with and without comorbid diabetes mellitus, Can. J. Psychiatry, 48, 458, 10.1177/070674370304800705 · DOI
  49. Schlogl, 2013, Exenatide-induced reduction in energy intake is associated with increase in hypothalamic connectivity, Diabetes Care, 36, 1933, 10.2337/dc12-1925 · DOI
  50. Shapiro, J., Mindra, S., Timmins, V., Swampillai, B., Scavone, A., Collinger, K., Collins, J., Goldstein, B.I., 2016. Controlled study of obesity among adolescents with bipolar disorder. J. Child Adolesc. Psychopharmacol. · DOI
  51. Shelton, 2015, Association of obesity and inflammatory marker levels on treatment outcome: results from a double-blind, randomized study of adjunctive l-methylfolate calcium in patients with MDD who are inadequate responders to SSRIs, J. Clin. Psychiatry, 76, 1635, 10.4088/JCP.14m09587 · DOI
  52. Snitz, 2013, Cognitive trajectories associated with beta-amyloid deposition in the oldest-old without dementia, Neurology, 80, 1378, 10.1212/WNL.0b013e31828c2fc8 · DOI
  53. Talbot, 2014, The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer’s disease, Alzheimers Dement, 10, S12, 10.1016/j.jalz.2013.12.007 · DOI
  54. Teramoto, 2011, Exendin-4, a glucagon-like peptide-1 receptor agonist, provides neuroprotection in mice transient focal cerebral ischemia, J. Cereb. Blood Flow. Metab., 31, 1696, 10.1038/jcbfm.2011.51 · DOI · Paper page
  55. van Bloemendaal, 2014, GLP-1 receptor activation modulates appetite- and reward-related brain areas in humans, Diabetes, 63, 4186, 10.2337/db14-0849 · DOI · Paper page
  56. Vancampfort, 2013, Metabolic syndrome and metabolic abnormalities in bipolar disorder: a meta-analysis of prevalence rates and moderators, Am. J. Psychiatry, 170, 265, 10.1176/appi.ajp.2012.12050620 · DOI · Paper page
  57. Wolinsky, 2013, A randomized controlled trial of cognitive training using a visual speed of processing intervention in middle aged and older adults, PLoS One, 8, e61624, 10.1371/journal.pone.0061624 · DOI · Paper page
  58. Yogi-Morren, 2014, Duration of type 2 diabetes and very low density lipoprotein levels are associated with cognitive dysfunction in metabolic syndrome, Cardiovasc. Psychiatry Neurol., 2014, 656341, 10.1155/2014/656341 · DOI

Cited by

Metadata

Authors
Mansur, R. B., Ahmed, J., Cha, D. S., Woldeyohannes, H. O., Subramaniapillai, M., Lovshin, J., Lee, J. G., Lee, J.-H., Brietzke, E., Reininghaus, E. Z., Sim, K., Vinberg, M., Rasgon, N., Hajek, T., & McIntyre, R. S.
Venue
Journal of Affective Disorders
Publisher
Elsevier BV
Published
2017-01
Volume
207
Pages
114-120
ISSN
0165-0327 (ISSN-L)
OpenAlex
W2527740737
Cited by
164
References
27
FWCI
11.35
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.